Form D · Biotechnology

Corvia Medical, Inc.

Tewksbury, MA · CIK 0001464449

Offering snapshot reported Jun 25, 2025 · SEC filing

Reported sold
$8.86M
Offering amount: $11.1M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 12, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 25, 2025Initial$8,860,552No comparison10SEC filing
Jan 25, 2021Initial$6,265,647No comparison25SEC filing
Sep 22, 2015Amendment$34,000,001$16,950,001vs Jul 1, 20149SEC filing
Jul 1, 2014Initial$17,050,000No comparison9SEC filing
Mar 15, 2013Initial$10,736,836No comparison10SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-549840

Source: Form D, filed Jun 25, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Gerald Brunk Director
Gerry Brunk Director
David Celermajer Director
Dan B. Curtis Executive
Daniel B. Curtis Executive
George J. Fazio Director, Executive
Uri Geiger Director
Kevin Gillis Director
Paul La Violette Director
Mark Levin Director
Hemant Taneja Director
Irit Yaniv Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1 Highwood Drive, Suite 300
Tewksbury, MA, 01876